|
|
||||||||
CASE REPORT |
From the Center for Health Sciences (Drs Baker and Stroup) and the Medical Center (Dr Gilstrap) at the Oklahoma State University in Tulsa.
Address correspondence to Jeffrey S. Stroup, PharmD, Oklahoma State University Center for Health Sciences, Department of Medicine, 635 W 11th St, Tulsa, OK 74127-9014. E-mail: jeffrey.stroup{at}okstate.edu
Chronic gout and rheumatoid arthritis are common medical manifestations with debilitating effects on patients. However, these conditions are not typically identified concomitantly and can be hard to distinguish from one another. We report a rare case of a 50-year-old white woman with a history of chronic gout and rheumatoid arthritis who presented with intradermal tophaceous gout. Physical examination and laboratory results are described.
Tophaceous gout is a less common condition that causes skin lesions called tophi. This disease occurs in patients with chronic gout and has been reported on finger pads, arms, thighs, buttocks, and the abdomen.4 Although typically painless, these lesions may ulcerate and drain with a white, chalky, urate matter.5
We describe a rare occurrence of concomitant gout and RA in a patient with multiple intradermal tophi. Although a few concurrent cases of gout and RA have been described,2,6-8 the present report is, to our knowledge, the first published incident of coexistent intradermal tophaceous gout and seronegative RA.
| Report of Case |
|---|
|
|
|---|
On admission at the OSU Medical Center, the patient's blood pressure was 160/96 mm Hg; heart rate, 105 beats per minute; body temperature, 102.9°F; and respiratory rate, 24 breaths per minute. On physical examination, the patient was noted as obese, alert and oriented, and in no acute distress. She had multiple pustules with a yellow center on her abdomen and fingers (Figure 1). Her wrists were bilaterally swollen and tender, and she complained of decreased range of bilateral motion in her metacarpophalangeal joints. She also had bilateral swelling and pain in her knees.
|
Radiographic scans of the patient's hands revealed bilateral juxta-articular osteopenia involving the metacarpophalangeal regions and bilateral symmetric radial and ulnar carpal joint space loss with associated erosive changes consistent with RA (Figure 2). The first metacarpophalangeal joint in the patient's left hand was subluxated and loss of the ulnar styloid was visible. Radiographic scans of the patient's feet also uncovered symmetric joint space narrowing with osteopenia (Figure 3). A wet mount specimen with polarized light microscopy of the punch biopsy for an abdominal skin lesion revealed monosodium urate crystals, which are indicative of tophaceous gout (Figure 4).
|
|
|
Because the patient had a history of gout and RA as well as an elevated serum creatinine level, consultations were obtained from the rheumatology and nephrology services 4 days after admission. Laboratory results from these consultations revealed a rheumatoid factor of <20 IU/mL; reticulocyte count, 3.08%; lactate dehydrogenase, 263 U/L; serum uric acid, 6.8 mg/dL; 24-hour urine protein, 2074 mg; and 24-hour urine uric acid, 432 mg. The low rheumatoid factor value indicated seronegative RA. The patient receivedprednisone, 40 mg/d, and colchicine, 0.6 mg/d, combination therapy for her rheumatologic conditions.
Although the patient's uric acid levels were within the normal range, tophaceous gout was also diagnosed as a result of the presence of monosodium urate crystals. In addition, the patient's elevated lactate dehydrogenase level and reticulocyte count indicated hemolytic anemia. A Coombs test was not performed because the patient had already received corticosteroids. Results from a peripheral smear suggested normocytic anemia with granulocytosis and thrombocytosis. However, this result may be attributed to the fact that the smear was performed after administration of steroids and packed red blood cells.
The patient was discharged 6 days after admission in stable condition. She had decreased shortness of breath, fatigue, and joint pain, as well as improved but not completely resolved tophi lesions. Because of the high serum creatinine level and the patient's noncompliance with her previous home medication regimen, the daily dose of allopurinol was decreased to 100 mg. Similarly, colchicine (0.6 mg/d) was used as an acute therapy and as a prophylactic agent with the "initiation" of allopurinol therapy (ie, the colchicine was used as if the patient was just started on allopurinol therapy in an acute flare). The patient's other medications on discharge included prednisone, 40 mg/d for 2 weeks, and weekly doses of alendronate, 70 mg, and etanercept, 50 mg.
| Comment |
|---|
|
|
|---|
Although symmetric joint involvement can be seen in chronic tophaceous gout, it is often mistaken for RA. Gout, however, typically presents with asymmetric erosive lesions that are "punched out" in appearance and have sclerotic margins.10 Although the patient's uric acid level was normal, the history of gout was confirmed through skin biopsy by the presence of monosodium urate crystals.
The reason for the lack of coexistence between these two diseases is still disputed. Hyperuricemia may produce an immunosuppressive effect on RA because rheumatoid factor is decreased in these patients.11 High concentrations of uric acid may function as an antioxidant and a free radical scavenger.12 There is also evidence to suggest that monosodium urate crystals may bind antigens such as immunoglobulin G and may block the activation of B and T cells, which are prominent in patients with RA.12
| Conclusion |
|---|
|
|
|---|
| Acknowledgment |
|---|
Submitted January 22, 2007; revision received April 2, 2007; accepted April 5, 2007.
| References |
|---|
|
|
|---|
2. Zonana-Nacach A, Alarcón GS, Daniel WW. Rheumatoid arthritis
preceding the onset of polyarticular tophaceous gout [letter]. Ann
Rheum Dis. 1996;55:489
-490.
3. O'Dell JR. Therapeutic strategies for rheumatoid arthritis.
N Engl J Med.2004; 350:2591
-2602.
4. Fam AG, Assaad D. Intradermal urate tophi. J Rheumatol. 1997;24:1126 -1131.[Medline]
5. Vázquez-Mellado J, Cuan A, Magaña M, Pineda C, Cazarín J, Pacheco-Tena C, et al. Intradermal tophi in gout: a case-control study. J Rheumatol.1999; 26:136 -140.[Medline]
6. Gordon TP, Ahern MJ, Reid C, Roberts-Thomson PJ. Studies on the
interaction of rheumatoid factor with monosodium urate crystals and case
report of coexistent tophaceous gout and rheumatoid arthritis. Ann
Rheum Dis. 1985;44:384
-389.
7. Raman D, Abdalla AM, Newton DRL, Haslock I. Coexistent rheumatoid
arthritis and tophaceous gout: a case report. Ann Rheum
Dis. 1981;40:427
-429.
8. Khosla P, Gogia A, Agarwal PK, Pahuja A, Jain S, Saxena KK. Concomitant gout and rheumatoid arthritis—a case report. Indian J Med Sci.2004; 58:349 -352.[Medline]
9. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315 -324.[Medline]
10. Schapira D, Stahl S, Izhak OB, Balbir-Gurman A, Nahir AM. Chronic tophaceous gouty arthritis mimicking rheumatoid arthritis. Semin Arthritis Rheum. 1999;29:56 -63.[Medline]
11. Bachmeyer C, Charoud A, Mougeot-Martin M. Rheumatoid nodules indicating seronegative rheumatoid arthritis in a patient with gout. Clin Rheumatol.2003; 22:154 -155.[Medline]
12. Spector AK, Christman RA. Coexistent gout and rheumatoid arthritis. J Am Podiatr Med Assoc.1989; 79:552 -558.[Abstract]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |